Portage Biotech (PRTG) Institutional Ownership $4.57 -0.12 (-2.56%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.62 +0.04 (+0.98%) As of 02/21/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Portage Biotech (NASDAQ:PRTG)CurrentInstitutional OwnershipPercentage13.36%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.42MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.11M Get PRTG Insider Trade Alerts Want to know when executives and insiders are buying or selling Portage Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRTG Institutional Buying and Selling by Quarter Portage Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC15,431$80K0.0%N/A1.470% 2/14/2025 Bison Wealth LLC19,272$100K0.0%-80.4%1.835% 11/20/2024 Virtu Financial LLC10,919$73K0.0%N/A1.041% 9/5/2024 Sanctuary Advisors LLC297,728$63K0.0%N/A28.355% 8/15/2024 Armistice Capital LLC1,501,780$319K0.0%-9.9%8.437% 2/13/2024 Armistice Capital LLC1,876,105$3.42M0.0%-4.7%10.540% 11/15/2023 Armistice Capital LLC1,968,105$4.11M0.1%N/A11.056% 8/14/2023 Bison Wealth LLC213,398$746K0.1%N/A1.199% 8/8/2023 Ieq Capital LLC16,650$58K0.0%N/A0.094% 5/10/2023 MAI Capital Management78,676$243K0.0%+36.8%0.464% Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023 MAI Capital Management57,512$304K0.0%N/A0.340% 11/14/2022Ergoteles LLC20,597$140K0.0%-11.6%0.122% 7/21/2022 Beacon Investment Advisory Services Inc.11,395$80K0.0%N/A0.085% 5/2/2022 Allspring Global Investments Holdings LLC8,189$53K0.0%N/A0.061% 4/20/2022 Sigma Planning Corp11,388$75K0.0%N/A0.085% 2/14/2022 Maven Securities LTD131,832$1.42M0.0%-41.3%0.989% 2/4/2022 Beacon Investment Advisory Services Inc.11,395$122K0.0%N/A0.086% 11/9/2021BlackRock Inc.213,123$4.33M0.0%+19.7%1.599% 11/4/2021 Deutsche Bank AG2,875$58K0.0%+34.3%0.022% 8/18/2021 Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021 Blackstone Inc65,000$1.36M0.0%N/A0.488% 8/16/2021 California State Teachers Retirement System5,050$106K0.0%N/A0.038% 8/16/2021 Maven Securities LTD278,694$6.33M0.3%N/A2.091% 8/16/2021 State Street Corp46,453$974K0.0%N/A0.349% 8/13/2021 Northern Trust Corp44,634$935K0.0%N/A0.335% 8/13/2021 Altium Capital Management LP75,000$1.57M0.4%N/A0.563% 8/13/2021 Geode Capital Management LLC35,039$734K0.0%N/A0.263% 8/13/2021 Vanguard Group Inc.13,107$275K0.0%N/A0.098% 8/12/2021 JPMorgan Chase & Co.4,746$99K0.0%N/A0.036% 8/12/2021 Monashee Investment Management LLC110,000$2.31M0.3%N/A0.825% 8/11/2021BlackRock Inc.178,027$3.73M0.0%N/A1.336% 8/11/2021 Deutsche Bank AG2,140$45K0.0%N/A0.016% 8/2/2021 New York State Common Retirement Fund3,900$82K0.0%N/A0.032% 5/21/2021 Beacon Investment Advisory Services Inc.11,395$319K0.0%N/A0.094% (Data available from 1/1/2016 forward) PRTG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRTG shares? During the previous two years, the following institutional investors and hedge funds held shares of Portage Biotech shares: Armistice Capital LLC ($319K), MAI Capital Management ($243K), Bison Wealth LLC ($100K), Citadel Advisors LLC ($80K), Virtu Financial LLC ($73K), and Sanctuary Advisors LLC ($63K), and Ieq Capital LLC ($58K).Learn more on PRTG's institutional investors. What percentage of Portage Biotech stock is owned by institutional investors? 13.36% of Portage Biotech stock is owned by institutional investors. Learn more on PRTG's institutional investor holdings. Which institutional investors have been buying Portage Biotech stock? The following institutional investors have purchased Portage Biotech stock in the last 24 months: Armistice Capital LLC ($1.97M), Sanctuary Advisors LLC ($297.73K), Bison Wealth LLC ($213.40K), MAI Capital Management ($21.16K), Ieq Capital LLC ($16.65K), Citadel Advisors LLC ($15.43K), and Virtu Financial LLC ($10.92K). How much institutional buying is happening at Portage Biotech? Institutional investors have bought a total of 2,543,395 shares in the last 24 months. This purchase volume represents approximately $101.05M in transactions. Which Portage Biotech major shareholders have been selling company stock? The following institutional investors have sold Portage Biotech stock in the last 24 months: Armistice Capital LLC ($256.11K), and Bison Wealth LLC ($79.25K). How much institutional selling is happening at Portage Biotech? Institutional investors have sold a total of 335,354 shares in the last 24 months. This volume of shares sold represents approximately $4.45M in transactions. Related Companies Leap Therapeutics Major Shareholders MIRA Pharmaceuticals Major Shareholders OnKure Therapeutics Major Shareholders NanoViricides Major Shareholders GlycoMimetics Major Shareholders Marker Therapeutics Major Shareholders Athira Pharma Major Shareholders MEI Pharma Major Shareholders Quantum Biopharma Major Shareholders Affimed Major Shareholders This page (NASDAQ:PRTG) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
